These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 688286)

  • 61. Adjuvant chemotherapy with 5-fluorouracil after surgical resection of colorectal carcinoma (COG protocol 7041). A preliminary report.
    Grage TD; Metter GE; Cornell GN; Strawitz JG; Hill GJ; Frelick RW; Moss SE
    Am J Surg; 1977 Jan; 133(1):59-66. PubMed ID: 835781
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-term ambulatory treatment of metastatic colorectal adenocarcinoma by continuous intravenous infusion of 5-fluorouracil.
    Quebbeman E; Ausman R; Hansen R; Becker T; Caballero G; Ritch P; Jenkins D; Blake D; Tangen L; Schulte W
    J Surg Oncol; 1985 Sep; 30(1):60-5. PubMed ID: 3935873
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Phase II evaluation of ftorafur in previously untreated colorectal cancer: a Southwest Oncology Group Study.
    Buroker T; Padilla F; Groppe C; Guy G; Quagliana J; McCracken J; Vaitkevicius VK; Hoogstraten B; Heilbrun L
    Cancer; 1979 Jul; 44(1):48-51. PubMed ID: 378365
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Phase II trial of iproplatin (CHIP) in previously untreated patients with colorectal cancer.
    Blitzer JB; Newman N; Ginsberg SJ; Louie A; Scalzo A; Poiesz B
    Am J Clin Oncol; 1988 Dec; 11(6):650-1. PubMed ID: 3189231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phase II trial of PCNU in advanced colorectal carcinoma. An Eastern Cooperative Oncology Group pilot study.
    Earhart RH; Moertel C; Hahn RG; Woodhouse CL; Ramirez G; Engstrom PF
    Am J Clin Oncol; 1984 Aug; 7(4):309-12. PubMed ID: 6741861
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Methyl-CCNU for patients with previously treated metastatic neuroblastoma--a phase II study.
    Evans AE; Bernstein I; Finklestein J; Klemperer M; Leikin S; Weiner JM; Hammond GD
    Cancer Treat Rep; 1977; 61(1):83-5. PubMed ID: 324623
    [No Abstract]   [Full Text] [Related]  

  • 67. A phase II study of alanosine in advanced large bowel carcinoma.
    Rubin J; Hineman V; Moertel CG; Schutt AJ; Hahn RG
    Am J Clin Oncol; 1983 Apr; 6(2):191-3. PubMed ID: 6829493
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Methyl-CCNU and ftorafur in treatment of rectosigmoidal tumors and ftorafur capsules in treatment of colorectal tumors.
    Mechl Z; Malír
    Recent Results Cancer Res; 1981; 79():59-64. PubMed ID: 6795699
    [No Abstract]   [Full Text] [Related]  

  • 69. Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.
    Moertel CG; Schutt AJ; Hahn RG; Marciniak TA; Reitemeier RJ
    Cancer Chemother Rep; 1975; 59(3):581-3. PubMed ID: 1243107
    [No Abstract]   [Full Text] [Related]  

  • 70. Carboplatin in patients with advanced colorectal cancer pretreated with fluoropyrimidines.
    Nolè F; Biganzoli L; Buzzoni R; Bajetta E
    Eur J Cancer; 1993; 29A(9):1330-1. PubMed ID: 8343280
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evaluation of melphalan, ICRF-159, and hydroxyurea in metastatic prostate cancer: a preliminary report.
    Kvols LK; Eagan RT; Myers RP
    Cancer Treat Rep; 1977; 61(2):311-2. PubMed ID: 326400
    [No Abstract]   [Full Text] [Related]  

  • 72. Phase II study of 9-10 anthracene-dicarboxaldehyde bis(4,5-dihydro-1H-imidazol-2-yl) hydrazone dihydrochloride (CL216,942; ADAH) in patients with advanced colorectal carcinoma.
    Rubin J; Kvols LK; Moertel CG; Jones AR; Hahn RG; O'Connell MJ
    Am J Clin Oncol; 1983 Aug; 6(4):477-9. PubMed ID: 6869319
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Aminocaproic acid (AMICAR) in advanced colorectal carcinoma.
    Petrelli NJ; Markus G; Herrera L; Corasanti J; Mittelman A
    J Surg Oncol; 1986 Oct; 33(2):109-11. PubMed ID: 3762181
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Nonsurgical treatments of colonic cancers: chemotherapy, immunotherapy, radiotherapy].
    Zeitoun P; Salas H
    Rev Prat; 1979 Mar; 29(13):1139-40, 1143-5. PubMed ID: 432498
    [No Abstract]   [Full Text] [Related]  

  • 75. Phase II trial of N-methylformamide in patients with advanced colorectal carcinoma.
    Tauer K; Kemeny N; Cheng E; Hollander P; Geller N
    Cancer Treat Rep; 1986 Jun; 70(6):813-4. PubMed ID: 3524831
    [No Abstract]   [Full Text] [Related]  

  • 76. Phase II study of daunorubicin in previously untreated patients with advanced colorectal carcinoma.
    Harvey J; Bonnem E; Grady K; Goodman A; Schein P
    Med Pediatr Oncol; 1985; 13(1):30-1. PubMed ID: 3969059
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of CCNU and misonidazole in the treatment of advanced colorectal cancer.
    Anagnost J; Bennett JM; Sutherland RM; Boros L; Siemann DW; Mulcahy RT
    Am J Clin Oncol; 1987 Jun; 10(3):213-5. PubMed ID: 3591741
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Colorectal carcinoma in adolescents implications regarding etiology.
    Pratt CB; Rivera G; Shanks E; Johnson WW; Howarth C; Terrell W; Kumar AP
    Cancer; 1977 Nov; 40(5 Suppl):2464-72. PubMed ID: 200342
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Doxifluridine (5'-dFUrd) in patients with advanced colorectal carcinoma. A phase II study.
    Fosså SD; Dahl O; Hoel R; Heier M; Loeb M
    Cancer Chemother Pharmacol; 1985; 15(2):161-3. PubMed ID: 2990750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Phase II trial of intravenous melphalan in advanced colorectal carcinoma.
    Moore DF; Pazdur R; Abbruzzese JL
    Invest New Drugs; 1994; 12(2):133-6. PubMed ID: 7860230
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.